Skip to content
Screener

CapEx at other companies

NeoGenomics logo
NeoGenomicsNEO
$8.22M+30.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$197K+286%
IQVIA logo
IQVIAIQV
$198M+31.1%
Guardant Health logo
Guardant HealthGH
$5.58M+25.1%
Natera, Inc. logo
Natera, Inc.NTRA
$22.14M+1.5%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$5.2M+10.3%

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M
Free cash flow-$30.1M

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s capex?
Tempus AI, Inc. (TEM) reported capex of -$22.53M in Q2 2026.
How has Tempus AI, Inc.'s capex changed year-over-year?
Tempus AI, Inc.'s capex decreased by 399.8% year-over-year, from $7.51M to -$22.53M.
What is the long-term trend for Tempus AI, Inc.'s capex?
Over 2 years (2022 to 2025), Tempus AI, Inc.'s capex has grown at a 7.0% compound annual growth rate (CAGR), from $18.38M to $21.05M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Tempus AI, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude